INT263872

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 3
Disease Relevance 2.50
Pain Relevance 0.11

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (Adra1d) plasma membrane (Adra1d) signal transducer activity (Adra1d)
Anatomy Link Frequency
bowel 1
upper 1
Adra1d (Mus musculus)
Pain Link Frequency Relevance Heat
imagery 261 92.84 High High
Somatostatin 36 59.32 Quite High
positron emission tomography 108 49.12 Quite Low
anesthesia 12 5.00 Very Low Very Low Very Low
lidocaine 6 5.00 Very Low Very Low Very Low
cerebral cortex 3 5.00 Very Low Very Low Very Low
Inflammation 3 5.00 Very Low Very Low Very Low
local anesthetic 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Carcinoid 18 100.00 Very High Very High Very High
Neuroblastoma 27 99.98 Very High Very High Very High
Syndrome 6 99.26 Very High Very High Very High
Cancer 639 91.96 High High
Pheochromocytoma 9 88.16 High High
Neuroendocrine Cancer 66 84.16 Quite High
Insulinoma 3 81.08 Quite High
Gastrinoma 6 79.92 Quite High
Disease 195 57.28 Quite High
Islet Cell Adenoma 3 8.88 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In addition, Adams and Baum [684] attempted intraoperative neuroblastoma localization with 111In-DTPA-D-Phe1-octreotide.
Localization (localization) of 111In-DTPA-D-Phe1-octreotide associated with neuroblastoma
1) Confidence 0.01 Published 2009 Journal World J Surg Oncol Section Body Doc Link PMC2653072 Disease Relevance 0.80 Pain Relevance 0
Surgical exploration is performed approximately 48 to 72 hours post-injection and is preceded by a bowel preparation to minimize the background radiation from physiologic bowel excretion of 111In-DTPA-D-Phe1-octreotide.
Localization (excretion) of 111In-DTPA-D-Phe1-octreotide in bowel
2) Confidence 0.01 Published 2009 Journal World J Surg Oncol Section Body Doc Link PMC2653072 Disease Relevance 0.55 Pain Relevance 0.11
Similarly, in 2005, Grossrubatscher et al [703] reported on a 28 year old female patient with Cushing's syndrome from an adrenocorticotrophin (ATCH)-secreting bronchial carcinoid who, two days after receiving a 4 mCi (148 MBq) intravenous injection of 111In-DTPA-D-Phe1-octreotide, underwent radioguided thoracoscopic surgery with the assistance of a gamma detection probe and which allowed for accurate localization and resection of multiple metastatic lymph nodes within the upper mediastinal region.


Localization (secreting) of 111In-DTPA-D-Phe1-octreotide in upper associated with carcinoid and syndrome
3) Confidence 0.01 Published 2009 Journal World J Surg Oncol Section Body Doc Link PMC2653072 Disease Relevance 1.15 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox